SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001354488-13-005172
Filing Date
2013-09-12
Accepted
2013-09-12 16:18:32
Documents
2
Period of Report
2013-09-12
Effectiveness Date
2013-09-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT immy_sc14a.htm DEF 14A 470443
2 img001.jpg GRAPHIC 7177
  Complete submission text file 0001354488-13-005172.txt   481717
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35814 | Film No.: 131094383
SIC: 2834 Pharmaceutical Preparations